After immunizing BALB/c mice with each BVAC expressing a different form of the HER2 antigen, HER2-specific antibody titers in the sera at different time points after immunization were determined by a binding assay using HER2-expressing CT26 (CT26/HER2) tumor cells (Figure 2A,B). This evidence concerns the gene ERBB2 and neoplasm.